InnovaRx Innova Health Strategies

G92.05

Immune effector cell-associated neurotoxicity syndrome, grade 5

Billable FY2026 2025-10-01 → 2026-09-30
Exclusions 8 never code together
G00-G99chapter
Excludes2
  • certain conditions originating in the perinatal period (P04-P96)P04-P96
  • certain infectious and parasitic diseases (A00-B99)A00-B99
  • complications of pregnancy, childbirth and the puerperium (O00-O9A)O00-O9A
  • congenital malformations, deformations, and chromosomal abnormalities (Q00-Q99)Q00-Q99
  • endocrine, nutritional and metabolic diseases (E00-E88)E00-E88
  • injury, poisoning and certain other consequences of external causes (S00-T88)S00-T88
  • neoplasms (C00-D49)C00-D49
  • symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified (R00-R94)R00-R94

Excludes2 — not included here, but the patient may have both. Code both when documented.

Instructional notes 6
G92.0code
Code first
  • underlying cause such as:
  • complications of immune effector cellular therapy (T80.82)T80.82
Code also
  • , if applicable, associated signs and symptoms, such as:
  • cerebral edema (G93.6)G93.6
  • unspecified convulsions (R56.9)R56.9
G92.05code
Inclusion terms
  • ICANS, grade 5
Index entries leading here 1
  • Syndrome — see also Disease
    • immune effector cell-associated neurotoxicity (ICANS) G92.00
Alongside this code 5 same parent — G92.0
Additional references
AHA Coding Clinic® Licence required

Official coding advice for this code. Published by the American Hospital Association. Not included in this installation.

Risk adjustment

Maps to no condition category in any loaded model.

Presence is a property of the code. Untick a model to hide it everywhere.

This code

Billable
yes
Code set
FY2026
Parent
G92.0
Block
G89-G99
Siblings
5

Present FY2024–FY2027.